5 finasteride brands, $4-17/mo, all bioequivalent. The Cipla flagship is $0.24/day.

Your finasteride doesn't care which name is on the bottle. The DHT inhibition is identical. What differs: the price, the manufacturer's track record, and whether the pharmacy is actually licensed.

Five brands ship through the personal-import lane in our routing. The most expensive 30-tab is roughly 4x the cheapest. Same molecule, same target receptor, same regulatory bioequivalence floor. The decision is operational, not pharmacological.

We route generic finasteride orders to licensed personal-import pharmacies — we have a financial reason for you to keep reading. The math below is the same whether the molecule comes from us, CVS, or Hims.

The molecule.

Finasteride 1mg is a Type II 5α-reductase inhibitor — it blocks the enzyme that converts testosterone to DHT in scalp follicles and prostate tissue. Daily dosing reduces serum DHT ~70% and scalp DHT ~64% (Drake 1999). That suppression is what stops follicle miniaturization.

Bioequivalence is the regulatory floor: under FDA 21 CFR 320, a generic must demonstrate that 90% CIs for Cmax and AUC fall within 80-125% of the reference brand. Every finasteride generic in this article has cleared that bar. The 1.4% sexual side effect rate from Kaufman 1998's PROPECIA pivotal is for the molecule itself — same on every brand below. (Ascertainment-bias breakdown lives here.)

The choice between brands is which factory's day job is making finasteride and how big a pack you want. Nothing else.

The 5-brand teardown.

Per-pack pricing through LiberaCure-routed personal-import pharmacies, May 2026. Generics pricing moves quarterly — re-check before relying on the exact number, but the band is stable.

For verified pack-size context, AllDayChemist lists Finpecia 1mg at $10 / 30-tab through $44 / 180-tab (per-tab $0.24-0.33), and Fincar 5mg at $20.50 / 30-tab through $52.28 / 90-tab (per-tab $0.58-0.68 — but quartered, that's $0.15-0.17 per 1.25mg dose). Our routed prices sit slightly under those list tiers because we're sourcing through a different supplier. Curlzfin's $4.20 sale price is meaningfully under the typical pack-list range — re-check that one before relying on it. Finjuv and F-Pecia have less consistent public pack-size disclosure — anchor on routed price, not inferred per-day math, for those three.

Why Cipla is the default.

Cipla, founded 1935 in Mumbai, is the company that broke Big Pharma's HIV antiretroviral monopoly in 2001 — offering the LMIC market the AIDS triple-cocktail at $1/day (~$350/year) when the same regimen was selling for ~$10,000-12,000/year in the West. That single act forced the global pricing reset that became the foundation of LMIC HIV treatment.

WHO Prequalification (the LMIC HIV/TB/malaria audit programme — finasteride isn't on the list, since hair drugs aren't on the WHO priority shelf) is the most demanding manufacturing audit standard outside USFDA inspection itself. Cipla's facilities clear it routinely, and their Goa and Indore plants are USFDA-inspected.

The factory that makes Cipla's Finpecia 1mg is the same factory category that makes their HIV antiretroviral exports.

Cipla has been manufacturing bioequivalent finasteride since the early 2000s, roughly five years after Merck's PROPECIA US launch in 1997. That's two-plus decades of continuous manufacturing on a molecule that, by global pharma standards, is simple chemistry. It's a side product of a company built on HIV/TB drug economics, not where the margin is.

Of the 7 generic finasteride SKUs we route, Cipla makes 4 — Finpecia 1mg, F-Pecia 1mg, Fincar 5mg, and Ricit 5mg. The other three are Canixa (Curlzfin), Healing Pharma (Finjuv, Healpecia), and Canbro (Finale).

Cipla isn't the only safe choice — it's the boring correct first-order choice, the same way Suhagra is for sildenafil. The packaging is unremarkable. The pill works the way Merck's Propecia works because it's the same molecule.

Reviews on bioequivalent generics measure the marketing, not the molecule.

Most "best finasteride brand" articles rank by user reviews. Reviews on bioequivalent generics measure two things: which brand had a marketing budget, and which user group ended up on which SKU. Neither measures the pill.

The 1.4% sexual side effect rate from Kaufman 1998 is for the molecule — finasteride 1mg, period. Same on Finpecia, F-Pecia, Curlzfin, Finjuv, generic Hims, Walmart's $4 generic, and Merck's brand Propecia. The molecule doesn't know which factory it came from once it hits your bloodstream.

If somebody on a forum says "I felt different on Finpecia than on Hims," they're describing regression to the mean from a multi-month restart, the placebo half of a binary "Indian vs American generic" expectation, or normal inter-batch variability — not a Cipla problem. The one real exception: an unlicensed pharmacy shipping something that wasn't finasteride at all is a pharmacy problem, not a brand problem.

The half-tab dose protocol.

Here's the part the dermatology aisle doesn't volunteer.

The dose-response curve for finasteride on hair is shallow. Drake 1999 dose-finding data: 0.2mg/day → ~56% scalp DHT reduction; 1mg → ~64%; 5mg → ~69%. Most of the hair benefit comes from the first 0.2-0.5mg. The rest is incremental returns.

The dose-response curve for sexual side effects, on the other hand, is steeper at higher doses. That's why the 1mg formulation got marketed for hair (not 5mg, even though 5mg was the original BPH dose). The ratio peaks around 1mg, but it doesn't fall off a cliff at 0.5mg.

Three operational angles this opens up:

1. The 5mg quarter — Fincar route. A $5 pill cutter splits a Fincar 5mg tablet (Cipla) into four 1.25mg pieces — ~120 doses out of one $15.42 / 30-tab pack. Effective per-month cost: ~$3.85/month, the cheapest route in the entire lane. 1.25mg DHT inhibition is roughly equivalent to 1mg, sometimes 1-2 points higher. For hair purposes, identical.

2. The 1mg half — half-dose protocol. Some dermatologists titrate users with mild side effects down to 0.5mg/day or 1mg every other day. Drake 1999 data suggests 0.5mg gives ~58-62% scalp DHT reduction — still therapeutic, with side effect frequency typically lower. Half a Curlzfin tab = ~$0.07/day at the sale price. This isn't a Merck-labeled regimen and there's no large RCT for equal hair outcomes at 0.5mg — the dose-response data supports the dose mechanically, not the equivalent-efficacy claim.

3. The 1mg quarter — extreme low-dose. 0.25mg/day extrapolates to roughly the same ~56-58% scalp DHT reduction as 0.2mg in Drake's data. Some users tolerate it better; the trade-off is you're closer to the slope of the curve, so under-dosing margin is thinner.

The equipment for all three is a $5 pill cutter. The reason Merck only ever sold 1mg: that's where the patent and the trial protocols anchored, not what's optimal for every user.

The 6-tier price reality.

The Walmart cash lane is the closest US competitor to routed pricing. If your local Walmart's $4-list covers finasteride (it generally does) and the in-person prescription friction is fine with you, that's a legitimate alternative — we'd say so to a friend.

The personal-import lane wins on pack-size flexibility (100/180-tab packs without prescription friction), on the Fincar quartering route, and on Cipla brand transparency. It loses on lead time (~2 weeks) and on payment friction (crypto vs card).

The Roman/Hims/Keeps tier exists because some users want async telehealth + card payment without thinking about anything. That's genuinely a real product — the $16-25/mo buys the questionnaire, the licensed-provider sign-off, and not having to know what 5α-reductase is. For users who want that, take that. For users who don't, the routed Cipla tier still cuts the same molecule by another 50-80%.

How to pick, by user type.

First-time user, simplest answer. Order Curlzfin 1mg. Cheapest 1mg SKU, $4.20 total commit at the current sale price. If you don't tolerate it after 4-8 weeks, you're out less than one cup of coffee. If you do, you've established baseline at the lowest cost in the lane.

Cost-optimizer with a pill cutter. Fincar 5mg (Cipla) + $5 pill cutter. Quarter each tablet — 1.25mg/dose, ~120 doses per pack. Effective: ~$3.85/month at the 30-tab tier, lower at 90-tab. The cheapest route in the entire lane, including Walmart's $4-list. Trade-off is quartering precision; for hair use, that variability is in the noise.

Side-effect-cautious user. Curlzfin or Finpecia 1mg, cut in half — 0.5mg/day. The half-dose protocol. Drake 1999 supports the DHT inhibition is still therapeutic, and many dermatologists titrate this way. No Merck-blessed RCT for equal hair outcomes at 0.5mg, but the dose-response data is real. (1.4% vs 30% side-effect breakdown lives here.)

Cipla loyalist already committed long-term. F-Pecia 1mg ($16.41 / 30-tab, $41.83 / 90-tab). Same Cipla factory as Finpecia, premium SKU — but Finpecia at $8.58 / 30-tab is the better $/tab pick. F-Pecia is mostly for users who specifically prefer that brand box.

Topical-curious user. Topical finasteride 0.25% — same molecule, scalp-applied, ~25-35% serum DHT reduction (vs 70% oral), side effect rates closer to placebo. Slightly lower hair efficacy is the trade-off. (Topical-vs-oral systemic-DHT breakdown is here.)

For the broader diagnostic and treatment-ladder framework, the hair-loss pillar guide is the long version.

A note on bias.

We route finasteride orders. Be aware of that.

LiberaCure routes orders to licensed personal-import pharmacies. Finpecia (by Cipla) is the finasteride SKU we ship most often — Cipla flagship, default 1mg recommendation.

F-Pecia (Cipla, bigger commit-pack), Fincar (Cipla 5mg, quartering route), and Ricit (Cipla 5mg) are the other three Cipla SKUs in active rotation. Curlzfin (Canixa) is the cheapest 1mg option. Finjuv (Healing Pharma) is the larger-pack alternative.

So we have a financial reason to want this article to lead you toward "give the routed lane a try."

We don't have an active Sun Pharma or Dr. Reddy's finasteride generic in stock right now — when we say "Cipla flagship is the default," that reflects what the catalog actually carries. The other Indian global-pharma giants make finasteride; we just don't carry those specific SKUs through this lane at the moment.

Policy: LiberaCure reships once free if tracking shows lost in transit. Second reship also free. Crypto refund (BTC/ETH/USDT) on third failure. Email reply 24-48h ([email protected]) — no live chat, no phone.

Read this with that in mind. The protocol above is what I'd tell a friend, not what maximizes reorder rate. If a competitor personal-import pharmacy is already shipping you Finpecia and the price is within the same band, don't switch on $0.05 per pill. A working supplier is worth more than that.

Sources:

• Kaufman KD et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol 1998;39(4 Pt 1):578-589 (PROPECIA pivotal trials, 1.4% sexual side effect baseline). PMID 9777765
• Drake L et al. The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia. J Am Acad Dermatol 1999;41(4):550-554 (dose-response data: 0.2mg / 1mg / 5mg DHT inhibition; 0.2mg = 56.5% scalp DHT). PMID 10495374
• Roberts JL et al. Clinical dose ranging studies with finasteride in men with male pattern hair loss. J Am Acad Dermatol 1999;41(4):555-563 (dose-finding pivotal data, 0.01-5mg).
• FDA Bioequivalence Guidance, 21 CFR 320 — 80-125% confidence interval rule for generic Cmax/AUC.
• FDA Orange Book finasteride generic AB-rating, accessed May 2026.
• Cipla Ltd. company filings — USFDA-inspected facility list, including Goa and Indore.
• AllDayChemist public list pricing, Finpecia 1mg and Fincar 5mg, snapshot May 2026. Re-verify before citing.
• Hims oral finasteride pricing ($22/mo "starting at"), accessed May 2026.
• Keeps oral finasteride pricing ($25/mo), accessed May 2026.

— LiberaCure editorial. We route generic medication through licensed personal-import pharmacies. We don't dispense, prescribe, or warehouse. Read more about why.